Advertisement

Approach to Encephalitis in the ICU

  • Anne Damian
  • Arun VenkatesanEmail author
Chapter
  • 10 Downloads

Abstract

Encephalitis refers to an inflammatory disorder of brain parenchyma, with a broad etiologic differential diagnosis. Encephalitis may present with a wide variety of associated neurologic symptoms, though most commonly presents with encephalopathy. Given the wide differential diagnosis for encephalopathy, a broad work-up is necessary to exclude alternate diagnoses. Encephalitis is associated with significant morbidity and mortality; therefore, prompt recognition and management is paramount to increasing the likelihood of a favorable outcome. Patients with encephalitis frequently require monitoring in a neurological ICU, often with prolonged admissions. This chapter will review a general approach to the care of adults with encephalitis, focusing on practical aspects of ICU management encephalitis and its complications.

Keywords

ADEM Arbovirus Autoimmune encephalitis Herpes simplex virus Limbic encephalitis Mycobacterium tuberculosis New-onset refractory status epilepticus SREAT 

References

  1. 1.
    Venkatesan A, Tunkel AR, Bloch KC, et al. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis. 2013;57(8):1114–28.  https://doi.org/10.1093/cid/cit458.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    George BP, Schneider EB, Venkatesan A. Encephalitis hospitalization rates and inpatient mortality in the United States, 2000–2010. In: Chaturvedi V, editor. PLoS One. 2014;9(9):e104169.  https://doi.org/10.1371/journal.pone.0104169.
  3. 3.
    Granerod J, Cousens S, Davies NWS, Crowcroft NS, Thomas SL. New estimates of incidence of encephalitis in England. Emerg Infect Dis. 2013;19(9).  https://doi.org/10.3201/eid1909.130064.
  4. 4.
    Boucher A, Herrmann JL, Morand P, et al. Epidemiology of infectious encephalitis causes in 2016. Med Mal Infect. 2017;47(3):221–35.  https://doi.org/10.1016/j.medmal.2017.02.003.CrossRefPubMedGoogle Scholar
  5. 5.
    Granerod J, Tam CC, Crowcroft NS, Davies NWSS, Borchert M, Thomas SL. Challenge of the unknown: a systematic review of acute encephalitis in non-outbreak situations. Neurology. 2010;75(10):924–32.  https://doi.org/10.1212/WNL.0b013e3181f11d65.CrossRefPubMedGoogle Scholar
  6. 6.
    Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10(1):63–74.  https://doi.org/10.1016/S1474-4422(10)70253-2.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Moragas M, Martínez-Yélamos S, Majós C, Fernández-Viladrich P, Rubio F, Arbizu T. Rhombencephalitis: a series of 97 patients. Medicine (Baltimore). 2011;90(4):256–61.  https://doi.org/10.1097/MD.0b013e318224b5af.CrossRefGoogle Scholar
  8. 8.
    Koelman DLH, Chahin S, Mar SS, et al. Acute disseminated encephalomyelitis in 228 patients. Neurology. 2016;86(22):2085–93.  https://doi.org/10.1212/wnl.0000000000002723.CrossRefPubMedGoogle Scholar
  9. 9.
    Sejvar JJ, Kohl KS, Bilynsky R, et al. Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2007;25(31):5771–92.  https://doi.org/10.1016/j.vaccine.2007.04.060.CrossRefPubMedGoogle Scholar
  10. 10.
    Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391–404.  https://doi.org/10.1016/S1474-4422(15)00401-9.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Glaser CA, Honarmand S, Anderson LJ, et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis. 2006;43(12):1565–77.  https://doi.org/10.1086/509330.CrossRefPubMedGoogle Scholar
  12. 12.
    Kolski H, Ford-Jones EL, Richardson S, et al. Etiology of acute childhood encephalitis at The Hospital for Sick Children, Toronto, 1994–1995. Clin Infect Dis. 1998;26(2):398–409. http://www.ncbi.nlm.nih.gov/pubmed/9502462CrossRefGoogle Scholar
  13. 13.
    Granerod J, Ambrose HE, Davies NW, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis. 2010;10(12):835–44.  https://doi.org/10.1016/S1473-3099(10)70222-X.CrossRefPubMedGoogle Scholar
  14. 14.
    Mailles A, Stahl J-P, Steering Committee and Investigators Group. Infectious encephalitis in France in 2007: a national prospective study. Clin Infect Dis. 2009;49(12):1838–47.  https://doi.org/10.1086/648419.
  15. 15.
    Ball R, Halsey N, Braun MM, et al. Development of case definitions for acute encephalopathy, encephalitis, and multiple sclerosis reports to the vaccine: adverse event reporting system. J Clin Epidemiol. 2002;55(8):819–24. http://www.ncbi.nlm.nih.gov/pubmed/12384197CrossRefGoogle Scholar
  16. 16.
    Glaser CA, Gilliam S, Schnurr D, et al. In search of encephalitis etiologies: diagnostic challenges in the California encephalitis project, 1998–2000. Clin Infect Dis. 2003;36(6):731–42.  https://doi.org/10.1086/367841.CrossRefPubMedGoogle Scholar
  17. 17.
    Harutyunyan G, Hauer L, Dünser MW, et al. Autoimmune encephalitis at the neurological intensive care unit: etiologies, reasons for admission and survival. Neurocrit Care. 2017;27(1):82–9.  https://doi.org/10.1007/s12028-016-0370-7.CrossRefGoogle Scholar
  18. 18.
    Solomon T, Michael BD, Smith PE, et al. Management of suspected viral encephalitis in adults—Association of British Neurologists and British Infection Association National Guidelines. J Infect. 2012;64(4):347–73.  https://doi.org/10.1016/j.jinf.2011.11.014.CrossRefPubMedGoogle Scholar
  19. 19.
    Simon DW, Da Silva YS, Zuccoli G, Clark RSB. Acute encephalitis. Crit Care Clin. 2013;29(2):259–77.  https://doi.org/10.1016/j.ccc.2013.01.001.CrossRefPubMedGoogle Scholar
  20. 20.
    Kramer AH. Viral encephalitis in the ICU. Crit Care Clin. 2013;29(3):621–49.  https://doi.org/10.1016/j.ccc.2013.03.011.CrossRefPubMedGoogle Scholar
  21. 21.
    Negrini B, Kelleher KJ, Wald ER. Cerebrospinal fluid findings in aseptic versus bacterial meningitis. Pediatrics. 2004;105(2):316–9.  https://doi.org/10.1542/peds.105.2.316.CrossRefGoogle Scholar
  22. 22.
    Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California encephalitis project. Clin Infect Dis. 2012;54(7):899–904.  https://doi.org/10.1093/cid/cir1038.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Steiner I, Budka H, Chaudhuri A, et al. Viral encephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol. 2005;12(5):331–43.  https://doi.org/10.1111/j.1468-1331.2005.01126.x.CrossRefPubMedGoogle Scholar
  24. 24.
    Schroth G, Kretzschmar K, Gawehn J, Voigt K. Advantage of magnetic resonance imaging in the diagnosis of cerebral infections. Neuroradiology. 1987;29(2):120–6. http://www.ncbi.nlm.nih.gov/pubmed/3587584CrossRefGoogle Scholar
  25. 25.
    Marchbank ND, Howlett DC, Sallomi DF, Hughes DV. Magnetic resonance imaging is preferred in diagnosing suspected cerebral infections. BMJ. 2000;320(7228):187–8. http://www.ncbi.nlm.nih.gov/pubmed/10634753CrossRefGoogle Scholar
  26. 26.
    Martinez-Torres F, Menon S, Pritsch M, et al. Protocol for German trial of acyclovir and corticosteroids in Herpes-simplex-virus-encephalitis (GACHE): a multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial [ISRCTN45122933]. BMC Neurol. 2008;8:40.  https://doi.org/10.1186/1471-2377-8-40.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Maraş Genç H, Uyur Yalçın E, Sayan M, et al. Clinical outcomes in children with herpes simplex encephalitis receiving steroid therapy. J Clin Virol. 2016;80:87–92.  https://doi.org/10.1016/j.jcv.2016.05.002.CrossRefPubMedGoogle Scholar
  28. 28.
    Sunwoo J-S, Lim J-A, Lee W-J, et al. Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort. Neurology. 2016;86(18):1683–91.  https://doi.org/10.1212/wnl.0000000000002635.CrossRefPubMedGoogle Scholar
  29. 29.
    Thakur KT, Motta M, Asemota AO, et al. Predictors of outcome in acute encephalitis. Neurology. 2013;81(9):793–800.  https://doi.org/10.1212/WNL.0b013e3182a2cc6d.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Viarasilpa T, Panyavachiraporn N, Osman G, et al. Electrographic seizures in patients with acute encephalitis. Neurocrit Care. 2019;30(1):207–15.  https://doi.org/10.1007/s12028-018-0599-4.CrossRefPubMedGoogle Scholar
  31. 31.
    Gaspard N, Foreman BP, Alvarez V, et al. New-onset refractory status epilepticus. Neurology. 2015;85(18):1604–13.  https://doi.org/10.1212/WNL.0000000000001940.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Sarkis RA, Coffey MJ, Cooper JJ, Hassan I, Lennox B. Anti-N -methyl-D-aspartate receptor encephalitis: a review of psychiatric phenotypes and management considerations: a report of the American Neuropsychiatric Association Committee on Research. J Neuropsychiatry Clin Neurosci. 2019;31(2):137–42.  https://doi.org/10.1176/appi.neuropsych.18010005.CrossRefPubMedGoogle Scholar
  33. 33.
    Schumacher LT, Mann AP, MacKenzie JG. Agitation Management in Pediatric Males with anti-N-methyl-d-aspartate receptor encephalitis. J Child Adolesc Psychopharmacol. 2016;26(10):939–43.  https://doi.org/10.1089/cap.2016.0102.CrossRefPubMedGoogle Scholar
  34. 34.
    Damato V, Balint B, Kienzler AK, Irani SR. The clinical features, underlying immunology, and treatment of autoantibody-mediated movement disorders. Mov Disord. 2018;33(9):1376–89.  https://doi.org/10.1002/mds.27446.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Venkatesan A. Epidemiology and outcomes of acute encephalitis. Curr Opin Neurol. 2015;28(3):277–82.  https://doi.org/10.1097/WCO.0000000000000199.CrossRefPubMedGoogle Scholar
  36. 36.
    Armangue T, Spatola M, Vlagea A, et al. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. Lancet Neurol. 2018;17(9):760–72.  https://doi.org/10.1016/S1474-4422(18)30244-8.

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of NeurologyJohns Hopkins Encephalitis Center, Johns Hopkins University School of MedicineBaltimoreUSA

Personalised recommendations